Adicet Bio, Inc. Common Stock (ACET) is a publicly traded Healthcare sector company. As of August 5, 2026, ACET trades at $9.10 with a market cap of $86.10M and a P/E ratio of -0.93. ACET moved -0.87% today. Year to date, ACET is +8.79%; over the trailing twelve months it is -20.48%. Its 52-week range spans $6.01 to $17.76. Analyst consensus is strong buy with an average price target of $20.50. Rallies surfaces ACET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACET financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACET recently traded at $9.10. Market cap is $86.10M. P/E ratio is -0.93. Revenue is $682.93M.
| Metric | Value |
|---|---|
| Price | $9.10 |
| Market Cap | $86.10M |
| P/E Ratio | -0.93 |
| EPS | $-9.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.76 |
| 52-Week Low | $6.01 |
| Volume | 41.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $682.93M |
| Net Income | $-346.15M |
| Gross Margin | 12.76% |
4 analysts cover ACET: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.50.